share_log

EFFECT: Others

EFFECT: Others

EFFECT:其他
美股SEC公告 ·  02/18 11:10

牛牛AI助理已提取核心訊息

Cardio Diagnostics Holdings has received notice from the U.S. Securities and Exchange Commission (SEC) regarding the effectiveness of its Form S-3 registration statement. The registration statement, filed under file number 333-284775, will become effective on February 14, 2025, at 5:00 P.M.Form S-3 is a simplified security registration document used by companies that have already met certain reporting requirements under the Securities Exchange Act of 1934. This registration enables the company to offer and sell various types of securities to the public.
Cardio Diagnostics Holdings has received notice from the U.S. Securities and Exchange Commission (SEC) regarding the effectiveness of its Form S-3 registration statement. The registration statement, filed under file number 333-284775, will become effective on February 14, 2025, at 5:00 P.M.Form S-3 is a simplified security registration document used by companies that have already met certain reporting requirements under the Securities Exchange Act of 1934. This registration enables the company to offer and sell various types of securities to the public.
Cardio Diagnostics Holdings 已收到美國證券交易委員會(SEC)關於其 S-3 表格註冊聲明有效性的通知。根據文件編號 333-284775 提交的註冊聲明將於 2025 年 2 月 14 日下午 5:00 生效。S-3 表格是一種簡化的安防註冊文件,用於已經滿足 1934 年證券交易法案下某些報告要求的公司。此註冊使公司能夠向公衆提供和賣出各種類型的安防。
Cardio Diagnostics Holdings 已收到美國證券交易委員會(SEC)關於其 S-3 表格註冊聲明有效性的通知。根據文件編號 333-284775 提交的註冊聲明將於 2025 年 2 月 14 日下午 5:00 生效。S-3 表格是一種簡化的安防註冊文件,用於已經滿足 1934 年證券交易法案下某些報告要求的公司。此註冊使公司能夠向公衆提供和賣出各種類型的安防。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
評論 評論 · 瀏覽 422

熱點推薦

聲明

本頁的譯文內容由軟件翻譯。富途將竭力但卻不能保證翻譯內容之準確和可靠,亦不會承擔因任何不準確或遺漏而引起的任何損失或損害。